Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 24 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax ...
Another COVID vaccine? Yes, and here’s why
Denver Post· 3 days agoThe federal government paid, on average, $20.69 per dose, and the cost of the new vaccine is likely to be higher. But vaccines save money ...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 4 days agoParticipants in the older group received either the new shot alone or Moderna's old COVID-19 vaccine...
Study: Short-duration spaceflights pose no significant health risks
UPI· 3 days agoThe first all-civilian space mission is shedding light on the potential health risks facing private...